Aareydrugs
Live Price
Recent news and updates for AAREYDRUGS will appear here soon.
"Robust technical setup for AAREYDRUGS with strong AI conviction. The bullish trend in the healthcare space is accelerating while RSI at 52 suggests there is still significant room for upside before reaching overbought territory."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, chlorinated solvent, glycols and glycol ethers, fiber intermediates, and acetates and esters, as well as industrial alcohols, ketones, amines, oleochemicals, intermediates, olefins, phosphates, fertilizers, monomers, and chemicals. Further, it offers lumefantrine; nimesulide; albendazole; carbamazepine; and oxcarbazepine. It serves pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India.
As of the latest market session, Aareydrugs (AAREYDRUGS) is trading at ₹106.26, representing a move of -4.13% from the previous close.
Aareydrugs is listed and traded under the ticker symbol AAREYDRUGS on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Aareydrugs's stock price moved by -4.13%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 65% bullish probability for AAREYDRUGS stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Aareydrugs shares reached a high of ₹114.8 and hit a low of ₹50.31.
AAREYDRUGS exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 3,49,224 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Aareydrugs has a market capitalization of ₹338.70 Cr, designating its size class inside the Healthcare sector.
Aareydrugs has a current dividend yield of N/A. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Aareydrugs's trailing Price-to-Earnings (P/E) ratio is 72.29. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Aareydrugs (AAREYDRUGS) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Aareydrugs's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore AAREYDRUGS's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for AAREYDRUGS are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Aareydrugs operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.